Literature DB >> 9259578

Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy.

P de Lonlay1, J C Fournet, J Rahier, M S Gross-Morand, F Poggi-Travert, V Foussier, J P Bonnefont, M C Brusset, F Brunelle, J J Robert, C Nihoul-Fékété, J M Saudubray, C Junien.   

Abstract

Sporadic persistent hyperinsulinemic hypoglycemia of infancy (PHHI) or nesidioblastosis is a heterogeneous disorder characterized by profound hypoglycemia due to inappropriate hypersecretion of insulin. An important diagnostic goal is to distinguish patients with a focal hyperplasia of islet cells of the pancreas (FoPHHI) from those with a diffuse abnormality of islets (DiPHHI) because management strategies differ significantly. 16 infants with sporadic PHHI resistant to diazoxide and who underwent pancreatectomy were investigated. Selective pancreatic venous sampling coupled with peroperative surgical examination and analysis of extemporaneous frozen sections allowed us to identify 10 cases with FoPHHI and 6 cases with DiPHHI. We show here that in cases of FoPHHI, but not those of DiPHHI, there was specific loss of maternal alleles of the imprinted chromosome region 11p15 in cells of the hyperplastic area of the pancreas but not in normal pancreatic cells. This somatic event is consistent with a proliferative monoclonal lesion. It involves disruption of the balance between monoallelic expression of several maternally and paternally expressed genes. Thus, we provide the first molecular explanation of the heterogeneity of sporadic forms of PHHI such that it is possible to perform only partial pancreatectomy, limited to the focal somatic lesion, so as to avoid iatrogenic diabetes in patients with focal adenomatous hyperplasia.

Entities:  

Mesh:

Year:  1997        PMID: 9259578      PMCID: PMC508251          DOI: 10.1172/JCI119594

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements.

Authors:  M P Lee; R J Hu; L A Johnson; A P Feinberg
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

2.  Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11.

Authors:  M Koi; L A Johnson; L M Kalikin; P F Little; Y Nakamura; A P Feinberg
Journal:  Science       Date:  1993-04-16       Impact factor: 47.728

3.  Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases.

Authors:  J Dubois; F Brunelle; G Touati; G Sebag; C Nuttin; T Thach; C Nikoul-Fekete; J Rahier; J M Saudubray
Journal:  Pediatr Radiol       Date:  1995

4.  Relaxation of imprinted genes in human cancer.

Authors:  S Rainier; L A Johnson; C J Dobry; A J Ping; P E Grundy; A P Feinberg
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

Review 5.  Nesidioblastosis and persistent neonatal hyperinsulinism.

Authors:  C Sempoux; F Poggi; F Brunelle; J M Saudubray; C Fekete; J Rahier
Journal:  Diabete Metab       Date:  1995-12

6.  Monoallelic expression of the human H19 gene.

Authors:  Y Zhang; B Tycko
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

7.  Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain.

Authors:  W Reik; K W Brown; H Schneid; Y Le Bouc; W Bickmore; E R Maher
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

8.  IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome.

Authors:  R Ohlsson; A Nyström; S Pfeifer-Ohlsson; V Töhönen; F Hedborg; P Schofield; F Flam; T J Ekström
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

9.  Somatic overgrowth associated with overexpression of insulin-like growth factor II.

Authors:  I M Morison; D M Becroft; T Taniguchi; C G Woods; A E Reeve
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

Authors:  S Matsuoka; J S Thompson; M C Edwards; J M Bartletta; P Grundy; L M Kalikin; J W Harper; S J Elledge; A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  57 in total

Review 1.  Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis.

Authors:  J M Saudubray; P de Lonlay; G Touati; D Martin; M C Nassogne; P Castelnau; C Sevin; C Laborde; C Baussan; M Brivet; A Vassault; D Rabier; J P Bonnefont; P Kamoun
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

2.  Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.

Authors:  H Huopio; F Reimann; R Ashfield; J Komulainen; H L Lenko; J Rahier; I Vauhkonen; J Kere; M Laakso; F Ashcroft; T Otonkoski
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide.

Authors:  C Boulanger; D Vezzosi; A Bennet; F Lorenzini; J Fauvel; P Caron
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 4.  Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism.

Authors:  Dunia Ismail; Khalid Hussain
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

5.  Chromosome 11 segmental paternal isodisomy in amniocytes from two fetuses with omphalocoele: new highlights on phenotype-genotype correlations in Beckwith-Wiedemann syndrome.

Authors:  F R Grati; L Turolla; P D'Ajello; A Ruggeri; M Miozzo; G Bracalente; D Baldo; L Laurino; R Boldorini; E Frate; N Surico; L Larizza; F Maggi; G Simoni
Journal:  J Med Genet       Date:  2007-01-26       Impact factor: 6.318

6.  Histologic and Molecular Profile of Pediatric Insulinomas: Evidence of a Paternal Parent-of-Origin Effect.

Authors:  Tricia R Bhatti; Karthik Ganapathy; Alison R Huppmann; Laura Conlin; Kara E Boodhansingh; Courtney MacMullen; Susan Becker; Linda M Ernst; N Scott Adzick; Eduardo D Ruchelli; Arupa Ganguly; Charles A Stanley
Journal:  J Clin Endocrinol Metab       Date:  2016-01-12       Impact factor: 5.958

Review 7.  Practical management of hyperinsulinism in infancy.

Authors:  A Aynsley-Green; K Hussain; J Hall; J M Saudubray; C Nihoul-Fékété; P De Lonlay-Debeney; F Brunelle; T Otonkoski; P Thornton; K J Lindley
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 8.  Genetics of neonatal hyperinsulinism.

Authors:  B Glaser; P Thornton; T Otonkoski; C Junien
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 9.  Genetic characteristics of patients with congenital hyperinsulinism.

Authors:  Mary Ellen Vajravelu; Diva D De León
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

10.  High Risk of Diabetes and Neurobehavioral Deficits in Individuals With Surgically Treated Hyperinsulinism.

Authors:  Katherine Lord; Jerilynn Radcliffe; Paul R Gallagher; N Scott Adzick; Charles A Stanley; Diva D De León
Journal:  J Clin Endocrinol Metab       Date:  2015-09-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.